We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$310M
AUM Growth
-$124M
Cap. Flow
-$12.5M
Cap. Flow %
-4.04%
Top 10 Hldgs %
68.81%
Holding
86
New
8
Increased
20
Reduced
4
Closed
13

Top Buys

Rank Stock Value
1
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$13.3M
2
CVEO icon
Civeo
CVEO
+$8.13M
3
HLLY icon
Holley
HLLY
+$6.53M
4
CMPS
Compass Pathways
CMPS
+$3.74M
5
NN icon
NextNav
NN
+$2.4M

Top Sells

Rank Stock Value
1
KVYO icon
Klaviyo
KVYO
+$44.5M
2
SLRN
ACELYRIN
SLRN
+$8.74M
3
MREO
Mereo BioPharma
MREO
+$2.35M
4
PVLA
Palvella Therapeutics
PVLA
+$2.12M
5
GOCO
GoHealth
GOCO
+$888K

Sector Composition

Rank Sector Weight
1 Healthcare 44.2%
2 Financials 32.56%
3 Technology 12.36%
4 Consumer Discretionary 6.99%
5 Energy 0.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMPS
26
Compass Pathways
CMPS
$1.83B
$3.25M 1.05%
1,135,828
+974,590
+604% +$3.74M
TNGX icon
27
Tango Therapeutics
TNGX
$4.41B
$2.91M 0.94%
2,121,652
+389,500
+22% +$957K
KROS icon
28
Keros Therapeutics
KROS
$221M
$2.71M 0.87%
266,033
+23,400
+10% +$272K
AQST icon
29
Aquestive Therapeutics
AQST
$494M
$2.67M 0.86%
920,000
+20,000
+2% +$60.5K
NN icon
30
NextNav
NN
$2.23B
$2.42M 0.78%
+198,760
New +$2.4M
GATE
31
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.37M 0.44%
91,429
– –
VRNA
32
DELISTED
Verona Pharma
VRNA
$1.16M 0.38%
+18,347
New +$1.1M
EPD icon
33
Enterprise Products Partners
EPD
$81.7B
$1.07M 0.34%
31,290
– –
ADCT icon
34
ADC Therapeutics
ADCT
$144M
$1.03M 0.33%
733,568
– –
INZY
35
DELISTED
Inozyme Pharma
INZY
$983K 0.32%
1,080,027
– –
GOCO
36
DELISTED
GoHealth
GOCO
$694K 0.22%
25,096
-58,168
-70% -$888K
MRKR icon
37
Marker Therapeutics
MRKR
$18.7M
$682K 0.22%
554,250
– –
AMOD
38
Alpha Modus Holdings
AMOD
$22.1M
$454K 0.15%
+9,852
New +$794K
ROIV icon
39
Roivant Sciences
ROIV
$26.2B
$394K 0.13%
39,003
– –
SHFS icon
40
SHF Holdings
SHFS
$1.13M
$326K 0.11%
75,897
+1
+0% +$7
CAH icon
41
Cardinal Health
CAH
$55.4B
$237K 0.08%
1,718
– –
RZLV
42
Rezolve AI
RZLV
$1.09B
$220K 0.07%
181,667
– –
SLND.WS icon
43
Southland Holdings Warrants
SLND.WS
$138K 0.04%
860,302
– –
NIOBW
44
NioCorp Developments Ltd Warrant
NIOBW
$79.3M
$123K 0.04%
766,527
– –
RZLVW
45
Rezolve AI Warrants
RZLVW
$5.64M
$121K 0.04%
603,429
– –
AMODW
46
Alpha Modus Holdings Warrant
AMODW
$316K
$106K 0.03%
1,854,665
+666,666
+56% +$44.7K
GATEW
47
DELISTED
Marblegate Acquisition Corp. Warrant
GATEW
$95.6K 0.03%
597,333
– –
CRML icon
48
Critical Metals Corp
CRML
$1.06B
$94.1K 0.03%
+67,718
New +$309K
BKSY.WS icon
49
BlackSky Technology Inc Warrants
BKSY.WS
$65.9K
$45.5K 0.01%
350,000
– –
OPTXW icon
50
Syntec Optics Holdings Warrant
OPTXW
$19.2M
$40.2K 0.01%
803,132
– –
1
2
3 4

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Blue Owl Capital Holdings's Q1 2025 Portfolio in Review

As of Q1 2025, Blue Owl Capital Holdings held 86 positions worth $310M, down 29% from $434M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Blue Owl Capital Holdings withdrew a net $12.5M in Q1 2025, closing 13 positions and reducing 4 holdings. Its most notable exit was Klaviyo, an estimated $44.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 51% a quarter earlier, followed by Financials and Technology.

Against the trend, Blue Owl Capital Holdings opened a new position in ProShares UltraPro QQQ worth $10M.

  • Blue Owl Capital Holdings's largest Q1 2025 buy was ProShares UltraPro QQQ: 350,000 shares worth $10M.
  • Blue Owl Capital Holdings added most to Holley in Q1 2025, an estimated $6.53M increase.
  • Blue Owl Capital Holdings's biggest Q1 2025 reduction was Palvella Therapeutics, cutting an estimated $2.12M.
  • Blue Owl Capital Holdings fully exited Klaviyo in Q1 2025, selling an estimated $44.5M.
  • Blue Owl Capital Holdings's ten largest holdings make up 69% of its $310M portfolio in Q1 2025.
  • Blue Owl Capital Holdings opened 8 new positions and closed 13 in Q1 2025.
  • Blue Owl Capital Holdings's portfolio value fell 29% quarter-over-quarter to $310M.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2025, filed 15 May 2025.